Micro-Cap Mania: CPOP Rockets 167% Amid Biotech & Digital Retail Rally
By ATTN Desk · Editorial oversight: Sean Han
Daily Market Recap: August 6, 2025
Today’s trading session saw broad-based gains across small-cap and mid-cap stocks, led by surging biotech and digital retail names. Every ticker in our sample closed sharply higher, with several more than doubling on heavy volume. Below is a concise table of key metrics, followed by an analysis of the day’s trends and standout movers.
Market Summary Table
| Ticker | ATTN Price | Current Price | Volume | Price Change % |
|---|---|---|---|---|
| LFMD | 5.21 | 6.62 | 11,120,173 | 27.20% |
| LNTH | 46.87 | 52.90 | 10,034,386 | 12.91% |
| LPSN | 0.86 | 1.14 | 57,587,820 | 33.32% |
| MYGN | 4.99 | 5.79 | 10,088,044 | 16.03% |
| OPFI | 9.74 | 11.40 | 1,510,200 | 17.10% |
| GUTS | 0.79 | 1.00 | 5,642,246 | 27.27% |
| CYRX | 7.69 | 8.72 | 5,421,047 | 13.47% |
| ATOM | 3.01 | 3.57 | 1,391,040 | 18.70% |
| AIMD | 2.13 | 3.31 | 76,269,668 | 55.17% |
| RMSG | 1.03 | 2.25 | 27,618,889 | 119.51% |
| KMT | 17.20 | 20.36 | 3,275,770 | 18.27% |
| LHAI | 4.97 | 7.15 | 2,032,051 | 44.02% |
| LZMH | 1.98 | 2.60 | 449,281 | 31.60% |
| BINI | 2.16 | 3.02 | 1,882,794 | 40.00% |
| HLLY | 2.06 | 2.63 | 961,653 | 27.49% |
| EOLS | 5.51 | 6.37 | 9,242,530 | 15.56% |
| CPOP | 0.35 | 0.94 | 19,512,291 | 167.17% |
| GO | 15.40 | 18.60 | 14,802,304 | 20.77% |
| SEAT | 15.15 | 26.28 | 1,007,256 | 73.51% |
| VSAT | 20.87 | 28.03 | 12,952,571 | 34.35% |
Market Trends and Patterns
Nearly all names in today’s universe enjoyed double-digit gains, underscoring a risk-on mood among traders. Penny stocks and sub-$5 issues led the rally, with eleven tickers up more than 25%. Volume was especially heavy in lower-priced shares—AIMD saw over 76 million shares change hands, LPSN topped 57 million, and CPOP nearly 20 million.
Biotech and medtech companies outperformed, driven by positive trial updates and strategic deal flow. Ainos, Inc. (AIMD) jumped 55% after a $2.1 million AI diagnostic order and trial approval, while CytRx (CYRX) added 13% on licensing news. Real Messenger (RMSG) more than doubled on speculation of partnerships and fresh analyst coverage.
Digital and consumer-oriented tickers also enjoyed sharp uplifts. Pop Culture Group (CPOP) soared 167% as investors digested its digital platform overhaul and grant initiatives. Vivid Seats (SEAT) rallied 74% following a stronger-than-expected Q2 report and marketplace expansion plans.
Biotech Surge by Michael Schiffer
Notable Movers
The most significant moves by both price and volume include:
- CPOP (+167%): A massive surge on nearly 20 million shares as digital enhancements and grant-making focus hit investor radar.
- RMSG (+120%): Heavy 27.6 million-share volume amid rumored real estate software tie-ups.
- AIMD (+55%): Biotech AI deal and clinical approval fueled buying interest, with 76.3 million shares traded.
- SEAT (+74%): Q2 revenue beat and strategic pivot to expand ticket offerings attracted buyers.
- LPSN (+33%) and VSAT (+34%): High turnover and sector-specific catalysts drove strong upticks.
Despite the broad rally, mid-cap names such as LNTH, OPFI, and KMT also delivered 12–18% gains on steady volume, reflecting an across-the-board appetite for growth and turnaround stories.
TL;DR
Today’s session was characterized by an aggressive rally in small and micro-cap stocks, with all 19 tracked tickers posting gains. Penny stocks led the charge—CPOP, RMSG, AIMD, and SEAT each logged 50–167% returns on outsized volume. Biotech catalysts and digital retail updates drove the best performers, while mid-caps added solid double-digit gains. Overall, the market displayed strong risk appetite and broad participation across sectors.